LFMD
LifeMD, Inc.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- InstitutionsBULLISH
Q2 2026: 14 added (0 new), 8 trimmed or exited.
- AnalystsBULLISH
13 of 14 rate it Buy or better. Every target is above the price.
- EstimatesFALLING
Current-quarter EPS estimate $0.170 → −$0.005 over 90 days. 0 up, 1 down in 30 days.
- Short sellersSTEADY
Short interest +2.2% to 7.56M shares. 10.4 days to cover, ≈15.7% of shares.
- TrendDOWNTREND
28% below its 50-day average. New closing low $2.08 on Oct 26.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| FEDERATED HERMES, INC. | DOUBLED | $11.3M |
| ROYCE & ASSOCIATES LP | TRIM | $2.6M |
| MARSHALL WACE, LLP | DOUBLED | $2.3M |
| Russell Investments Group, Ltd. | DOUBLED | $1.3M |
| BANK OF AMERICA CORP /DE/ | DOUBLED | $1.1M |
| UBS Group AG | TRIM | $865.8K |
| SEI INVESTMENTS CO | DOUBLED | $573.9K |
| GOLDMAN SACHS GROUP INC | NEAR_EXIT | $411.4K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
14 analystsPrice is below the lowest target. Median implies +261%.Targets as of Oct 26, 2026.
| Date | Firm | Rating |
|---|---|---|
| Sep 17, 2026 | HC Wainwright & Co. REITERATE | Buy |
| Aug 7, 2026 | HC Wainwright & Co. MAINTAIN | Buy |
| Aug 6, 2026 | B. Riley Securities MAINTAIN | Buy |
| Aug 6, 2026 | BTIG MAINTAIN | Buy |
| May 26, 2026 | HC Wainwright & Co. REITERATE | Buy |
| May 4, 2026 | BTIG REITERATE | Buy |
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Aug 11, 2026 | DiTrolio Joseph Director | AWARD | 35,000 sh |
| Aug 11, 2026 | Simon Roberto Director | AWARD | 35,000 sh |
| Aug 11, 2026 | MACRAE CALUM ARCHIBALD Director | AWARD | 35,000 sh |
| Aug 11, 2026 | Strawn John R Jr Director | AWARD | 35,000 sh |
| Aug 11, 2026 | LAROVERE JOAN Director | AWARD | 35,000 sh |
| Jun 1, 2026 | Sripad Umesh Chief Technology Officer | AWARD | 75,000 sh |
| May 11, 2026 | Kavthekar Atul Chief Financial Officer | AWARD | 337,500 sh |
| May 4, 2026 | Strawn John R Jr Director | AWARD | 50,000 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.01 | -$0.02–$0.01 | -102.9% | $48.8M |
| Next Q | $0.07 | $0.06–$0.09 | -46.4% | $61.5M |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | $0.38 | $0.27–$0.49 | -26.2% | $245.1M |
Short side
FINRA· Sep 30, 2026SecBot reports
3 filings · 4 press releases · 0 bullish · 1 bearish · 2 neutral- NEUTRAL SC 13G/AOct 7, 2026
Federated Hermes, Inc. filed an amendment to its Schedule 13G, reporting beneficial ownership of…
Monitor for any future conversion to Schedule 13D, which would signal activist intent. For now, Federated Hermes remains a passive holder with no change in position.
- NEUTRAL PRESS RELEASESep 22, 2026
LifeMD declared a routine quarterly cash dividend of $0.5546875 per share on its 8.875% Series A…
This is a standard preferred dividend declaration with no read-through for common stock holders. Monitor LifeMD's next earnings release for operational performance.
- BEARISH PRESS-RELEASEAug 5, 2026
LifeMD reported Q2 2026 revenue of $47.3M (within guidance of $47M-$50M) but a significant EPS…
The severe EPS miss and guidance cut are bearish, but the stock may find support if the market focuses on the H2 return to positive EBITDA and the ~$250M exit run rate. Watch for Q3 2026 results and…
- NEUTRAL PRESS-RELEASEApr 27, 2026
LifeMD, Inc. announced it will report its Q1 2026 results on May 6.
All LFMD filing & press-release reports (7)
- SC 13G/A reportOct 7, 2026
- PRESS-RELEASE reportSep 22, 2026
- PRESS-RELEASE reportAug 5, 2026
- PRESS-RELEASE reportApr 27, 2026
- PRESS-RELEASE reportMar 31, 2026
- PRESS-RELEASE reportMar 24, 2026
- PRESS-RELEASE reportMar 9, 2026